$1.25 Million Prostate Cancer Research Grant

Prostate Cancer Research Team

Prostate cancer research team including Drs. Roseline Godbout (absent from photo), Adam Kinnaird (2^nd left), and Ron Moore (left) (Co-Principle Investigators) have been awarded a $1.25 million, four-year Alberta Cancer Foundation “Game Changer Grant” to investigate the link between fat metabolism and prostate cancer progression. The lead on this team grant is Dr. Roseline Godbout of Experimental Oncology. Other team members from Oncology are Drs. Liang Li, Helene Lemieux, Michael Hendzel, Jack Tuszynski, Rong-Zong Liu (2^nd from right), Hua Chen (3^rd from left). Other lab members in the photo include Dr. Abul Azad (3^rd  from right) (research associate - Moore Lab) and Guocheng Huang (right) (graduate student Kinnaird- Lab). Dr. Moore says, “This grant builds on our previously published research on fatty acid binding protein (FABP12) and Prostate Cancer aggressiveness as evident by epithelial to mesenchymal transition (EMT). FABP12 may be drugable for treatment and imaging of high-risk prostate cancer. We are working to precision medicine with prostate organoids derived from targeted prostate needle biopsies.”